MILLIONS of cancer sufferers have been given fresh hope of a cure after ground-breaking research.
The breakthrough came in a 16-year study of the only animal immune to cancer.
The discovery by an Israeli specialist was last night hailed as “radical and potentially life-changing”.
In  a world first, Professor Aaron Avivi and his team found that cells from  the blind mole rat and its cousin the naked mole rat secrete a  substance that destroys cancer cells in mammals – including humans.
Experts  think harvesting this substance and making it safe to digest could wipe  out a disease that kills eight million people each year worldwide. Last  night Prof Avivi, of Haifa University in Israel was heading to London  where he is due  to present his findings to professionals.
His  radical approach studied the two species of rat that both live mostly  underground – which the team discovered had led to a dramatic evolution  of their metabolism.
Blind mole rats outlive  other rodents by at least 20 years with no outward signs of ageing.  Researchers have never located a cancerous tumour on one of them.
The  team tested the underground rodents and regular mice and rats with two  potent carcinogens. Ordinary mice and rats developed tumours – none was  found in the subterranean rats.
The study,  published in the widely respected BMC Biology Journal, concluded: “Blind  mole rats are resistant to spontaneous cancer but also to  experimentally induced cancer.
“It shows the  unique ability of the blind mole rat to inhibit growth and kill cancer  cells, but not normal cells. It has evolved efficient anti-cancer  mechanisms.
“Exploring the molecular mechanisms  may hold the key for understanding the nature of resistance to cancer  and identify new strategies for treating humans.”
The  study was described as “exciting” by Prof Penella Woll, of the  University of Sheffield’s department of oncology. She said: “Other  researchers have taken a similar approach, studying sea creatures with  intrinsic cancer resistance to develop the anti-cancer drug trabectedin  – so we know that this can succeed.”
 
No comments:
Post a Comment